Customers Bancorp Inc (CUBI) Jumps 7.07% on January 21

Equities Staff  |

Customers Bancorp Inc (CUBI) was among the biggest gainers on the Russell 2000 for Thursday January 21 as the stock popped 7.07% to $24.99, representing a gain of $1.65 per share. Some 277,886 shares traded hands on 2,677 trades, compared with an average daily volume of 188,309 shares out of a total float of 26.88 million. The stock opened at $25.00 and traded with an intraday range of $26.66 to $24.43.

After today's gains, Customers Bancorp Inc reached a market cap of $671.79 million. Customers Bancorp Inc has had a trading range between $31.63 and $18.22 over the last year, and it had a 50-day SMA of $27.97 and a 200-day SMA of $26.22.

The stock has a P/E Ratio of 12.6.

Customers Bancorp Inc provides financial products and services to small businesses, not-for-profits, and consumers. It also provides liquidity to the mortgage market nationwide through the operation of its loans to mortgage banking companies business.

Customers Bancorp Inc is based out of Wyomissing, PA and has some 484 employees. Its CEO is Jay S. Sidhu.

For a complete fundamental analysis analysis of Customers Bancorp Inc, check out’s Stock Valuation Analysis report for CUBI. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










Can the Media Solve the Partisan Conflict?

Andrew McCarthy, Contributing Editor, The National Review; Michael Zeldin, CNN Legal Analyst; Celeste Katz, Senior Political Reporter, Glamour; Silvia Davi, SVP, Contributing Editor,; and Doug Simon, CEO, D S Simon Media discuss how the media’s role has shaped the landscape for communicators and what the media is trying to do to reduce discord in society.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.